Clinical Trials
4
Active:0
Completed:4
Trial Phases
1 Phases
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (100.0%)Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Phase 2
Completed
- Conditions
- Moderate to Severe GoutHyperuricemia
- Interventions
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- Nuon Therapeutics, Inc.
- Target Recruit Count
- 112
- Registration Number
- NCT01109121
- Locations
- 🇺🇸
Nuon Investigative Site, Spokane, Washington, United States
Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
Phase 2
Completed
- Conditions
- GoutHyperuricemia
- Interventions
- Drug: High dose combination
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- Nuon Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01052987
- Locations
- 🇺🇸
Nuon Investigative Site, Dallas, Texas, United States
Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
Phase 2
Completed
- Conditions
- GoutHyperuricemia
- Interventions
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- Nuon Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00995618
- Locations
- 🇺🇸
Nuon Investigative Site, Dallas, Texas, United States
Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- Nuon Therapeutics, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT00882024
News
No news found